List of Beyaz drug patents
Beyaz is owned by Bayer Hlthcare.
Beyaz contains Drospirenone; Ethinyl Estradiol; Levomefolate Calcium.
Beyaz has a total of 3 drug patents out of which 2 drug patents have expired.
Expired drug patents of Beyaz are:
- US7163931
- US6441168
Beyaz was authorised for market use on 24 September, 2010.
Beyaz is available in tablet;oral dosage forms.
Beyaz can be used as prevention of pregnancy.
The generics of Beyaz are possible to be released after 08 February, 2030.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6441168 | BAYER HLTHCARE | Stable crystalline salts of 5-methyltetrahydrofolic acid |
Jul, 2022
(10 months ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7163931 | BAYER HLTHCARE | Compositions of estrogen-cyclodextrin complexes |
Mar, 2022
(1 year, 3 months ago) | |
| US8617597 | BAYER HLTHCARE | Pharmaceutical composition containing a tetrahydrofolic acid |
Feb, 2030
(6 years from now) | |
Drugs and Companies using DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM ingredient
Market Authorisation Date: 24 September, 2010
Treatment: Prevention of pregnancy
Dosage: TABLET;ORAL
BEYAZ family patents
8
United States
3
Australia
3
Korea, Republic of
3
European Union
2
EA
2
Israel
2
Croatia
2
Canada
2
Denmark
2
Spain
2
ME
2
Czech Republic
2
Japan
2
Slovenia
2
China
2
Hungary
1
IB
1
Yugoslavia
1
New Zealand
1
Uruguay
1
Peru
1
Austria
1
Cyprus
1
Slovakia
1
Estonia
1
Bulgaria
1
Portugal
1
Ukraine
1
Poland
1
Norway
1
Hong Kong
1
Germany
1
Mexico
1
Argentina
1
RS
1
South Africa
1
Brazil
1
Taiwan
1
Lithuania
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic